Biophytis SA

04/18/2024 | Press release | Distributed by Public on 04/17/2024 23:06

Biophytis announces new Scientific Advisory Board for its phase 2 OBA clinical study in obesity

Biophytis announces new Scientific Advisory Board for its phase 2 OBA clinical study in obesity

18 Apr 2024 07:00 CEST

Subscribe

Issuer

BIOPHYTIS

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1245989_2024_04_18_PR_SAB_OBA.pdf

Source

Biophytis

Provider

Les Echos

Company Name

BIOPHYTIS

ISIN

FR0012816825

Symbol

ALBPS

Market

Euronext Growth